Morton Kanter Schwartz
#145,156
Most Influential Person Now
Morton Kanter Schwartz's AcademicInfluence.com Rankings
Morton Kanter Schwartzphilosophy Degrees
Philosophy
#7777
World Rank
#11032
Historical Rank
Logic
#4814
World Rank
#6143
Historical Rank

Download Badge
Philosophy
Morton Kanter Schwartz's Degrees
- Doctorate Medicine University of California, San Francisco
Why Is Morton Kanter Schwartz Influential?
(Suggest an Edit or Addition)Morton Kanter Schwartz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. (1978) (470)
- Inhibition of leukemias in man by L-asparaginase. (1967) (306)
- Toxicity of E. coli L‐asparaginase in man (1970) (287)
- Role of trace elements in cancer. (1975) (251)
- Alphafetoprotein and human chorionic gonadotropin determination in cerebrospinal fluid. An aid to the diagnosis and management of intracranial germ-cell tumors. (1979) (198)
- Pathological review of breast lesions analyzed for estrogen receptor protein. (1975) (195)
- Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor (1981) (175)
- Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection (1990) (158)
- Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. (2000) (144)
- Partial purification of a serum factor that causes necrosis of tumors. (1976) (138)
- Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate. (2005) (129)
- Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. (1978) (127)
- Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. (1977) (113)
- Estrone and estradiol content in human breast tumors: relationship to estradiol receptors. (1977) (109)
- Glutathione metabolism in newborns: Evidence for glutathione deficiency in plasma, bronchoalveolar lavage fluid, and lymphocytes in prematures (1995) (108)
- Cerebrospinal fluid biochemical markers of central nervous system metastases (1980) (108)
- Estrogen and progesterone receptors in breast carcinoma: Correlations with epidemiology and pathology (1981) (106)
- Steroid hormone accumulation in human breast cyst fluid. (1981) (103)
- Carcinoembryonic antigen: its role as a marker in the management of cancer. A National Institutes of Health Consensus Development Conference. (1981) (103)
- Cerebrospinal fluid (β2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment (1992) (98)
- The value of diagnostic aids in detecting pancreas cancer (1978) (93)
- Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. (2002) (92)
- COMPARATIVE EFFECTS OF L-HISTIDINE ON THE ACTIVITIES OF 5'-NUCLEOTIDASE AND ALKALINE PHOSPHATASE. (1963) (91)
- A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms. (1978) (90)
- Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancer (1977) (88)
- Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancer. (2001) (80)
- Tissue cathepsins as tumor markers. (1995) (75)
- Enzymes in cancer. (1973) (74)
- Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigen. (1989) (66)
- CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer. (1991) (60)
- L‐asparaginase activity in plasma and other biological fluids (1970) (58)
- Dietary Zinc Deficiency Decreases Plasma Concentrations of Vitamin E 1 (1989) (57)
- Genetic testing and the clinical laboratory improvement amendments of 1988: present and future. (1999) (56)
- CEA (carcinoembryonic antigen): Its role as a marker in the management of cancer (2004) (56)
- Correlation between estrogen receptor protein and carcinoembryonic antigen in normal and carcinomatous human breast tissue. (1976) (55)
- Monitoring Therapy by Serum HER-2/Neu (2000) (55)
- Abnormally high concentrations of beta 2 microglobulin in acquired immunodeficiency syndrome (AIDS) patients. (1983) (52)
- Serum 5′‐nucleotidase in patients with cancer (1965) (52)
- [55] Lactic dehydrogenase (clinical aspects) (1966) (52)
- Accumulation of hormones in breast cyst fluid. (1979) (51)
- Procedure for staining zones of activity of glutamic oxaloacetic transaminase following electrophoresis with starch gel. (1963) (50)
- Enzymes as prognostic markers and therapeutic indicators in patients with cancer. (1992) (50)
- Beta 2-microglobulin as a prognostic marker for development of AIDS. (1985) (50)
- Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer patients. (1981) (48)
- Cerebrospinal fluid biochemical markers in central nervous system tumors: a review. (1981) (47)
- Accuracy of Fecal Occult Blood Test Interpretation (1991) (45)
- Evaluation of CA M26, CA M29, CA 15-3 and CEA as circulating tumor markers in breast cancer patients. (1991) (45)
- Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy. (1993) (42)
- Automated assay of activities of enzymes involving the diphosphopyridine nucleotide-reduced diphosphopyridine nucleotide reaction. (1961) (40)
- Interferences in diagnostic biochemical procedures. (1973) (39)
- Cation levels in human breast cyst fluid. (1981) (37)
- Strategies of organization and service for the critical-care laboratory. (1990) (37)
- Abbott IMx evaluated for assay of prostate-specific antigen in serum. (1992) (36)
- L-2-oxothiazolidine-4-carboxylate, a cysteine precursor, stimulates growth and normalizes tissue glutathione concentrations in rats fed a sulfur amino acid-deficient diet. (1995) (34)
- Carcinoembryonic antigen in colonic lavage. (1977) (34)
- Estrogen receptor protein of breast cancer in patients with positive nodes. High recurrence rates in the postmenopausal estrogen receptor-negative group. (1987) (31)
- Enzymes in cancer. (1989) (30)
- Roche RIA and Abbott EIA carcinoembryonic antigen assays compared. (1984) (30)
- Acid phosphatases; a review. (1954) (30)
- CEA-like material in fluid from benign cysts of the breast. (1974) (29)
- [261c] Clinical aspects of aspartate and alanine aminotransferases☆☆☆★ (1971) (29)
- Selective inhibition of terminal deoxynucleotidyl transferase (TdT) by adenosine ribonucleoside triphosphate (ATP) and its application in the detection of TdT in human leukemia. (1977) (28)
- Automated approaches to rapid-response testing. A comparative evaluation of point-of-care and centralized laboratory testing. (1995) (28)
- Metabolism in surgical patients. I. Nitrogen metabolism in totally gastrectomized patients. (1956) (28)
- AUTOMATED METHODS FOR DETERMINATION OF ENZYME ACTIVITY. (1963) (27)
- Infectious hepatitis; correlation of clinical and laboratory findings, including serum enzyme changes. (1959) (27)
- Lactic dehydrogenase. An old enzyme reborn as a cancer marker? (1991) (26)
- The false-negative hemoccult test. (1977) (26)
- PROPERTIES OF ACTIVITY OF 5'-NUCLEOTIDASE IN HUMAN SERUM, AND APPLICATIONS IN DIAGNOSIS. (1964) (24)
- CLINICAL APPLICATION OF PHOSPHOHYDROLASE MEASUREMENTS IN CANCER * (1969) (24)
- Plasma lipid bound sialic acid in patients with prostate and bladder cancer. (1981) (24)
- Polyinosinic-Polycytidylic Acid Toxicity (1971) (24)
- Urinary cystathionine, catecholamine, and metabolites in patients with neuroblastoma. (1972) (24)
- Comparison of serum alkaline phosphatase activities determined with sodium beta-glycerophosphate and sodium phenylphosphate as substrates. (1960) (23)
- International Federation of Clinical Chemistry, Education Committee and International Union of Pure and Applied Chemistry, Division of Clinical Chemistry: definition of the terms certification, licensure and accreditation in clinical chemistry. (1985) (23)
- Relationship of the electrophoretic patterns of phosphohexose isomerase and glutamic oxyaloacetic transaminase in human tissues to the patterns in serum of patients with neoplastic disease. (1966) (22)
- Lipid-bound sialic acid as a tumor marker. (1983) (21)
- Isozymes of aspartate aminotransferase in tissues and blood of man. (1966) (21)
- CA 549 as a Marker in Breast Cancer (1991) (20)
- Regenerative Hyperplasia of the Liver Following Major Hepatectomy: Chemical Analysis of the Regenerated Liver and Comparative Nuclear Counts (1959) (19)
- Lactic acid dehydrogenase during pregnancy and puerperium. (1959) (19)
- Glucosephosphate isomerase as a CSF marker for leptomeningeal metastasis (1991) (19)
- (Washington University Case Conference). Colorectal carcinoma and carcinoembryonic antigen (CEA). (1980) (19)
- Fat and nitrogen metabolism in patients with massive small bowel resections. (1956) (18)
- Murine mammary tumor virus related antigen in human male mammary carcinoma (1983) (18)
- Chemical and clinical evaluation of the continuous-flow analyzer "SMAC". (1974) (17)
- The clinical utility of plasma and urinary carcinoembryonic antigen in patients with genitourinary disease. (1977) (17)
- Barr body distribution and estrogen receptor protein in mammary carcinoma. (1977) (17)
- Metabolism in surgical patients. II. Fat and mineral metabolism in totally gastrectomized patients. (1956) (17)
- Measurement of carcinoembryonic antigen. (1973) (16)
- Two whole-blood multi-analyte analyzers evaluated. (1989) (16)
- Measurement of the estradiol receptor in human breast tissue by the immobilized antibody method. (1975) (16)
- Multicenter Evaluation of the Performance and Clinical Utility in Longitudinal Monitoring of the Bayer Immuno 1™ Complexed PSA Assay (1999) (16)
- Enzymes used in predicting high risk to colon cancer. (1990) (16)
- Effect of phosphate in enhancing the action of triiodothyronine. (1956) (15)
- Studies of the physiology of the dumping syndrome. (1955) (15)
- Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus. (1989) (15)
- The effect of a gluten-free diet on fat, nitrogen, and mineral metabolism in patients with sprue. (1957) (15)
- Utilization of automation for studies of enzyme kinetics. (1968) (15)
- Diagnostic biochemical methods in pancreatic disease. (1970) (15)
- Accuracy of fecal occult blood test interpretation. National Polyp Study Work Group. (1991) (15)
- Serum Adenosine Deaminase Activity in Cancer.† (1959) (14)
- Detection of terminal deoxynucleotidyl transferase (TdT) by flow cytometry in leukemic disorders. (1989) (14)
- Metastatic adrenal cortical carcinoma: biochemical changes accompanying clinical regression during therapy with o,p'-DDD. (1971) (14)
- Variation in the quantitation of prostate-specific antigen in reference material: differences in commercial immunoassays. (1998) (14)
- Serum relaxin and human chorionic gonadotropin concentrations in spontaneous abortions. (1981) (13)
- Current status of tumour markers. (1995) (13)
- Bayer immuno 1™ PSA assay: An automated, ultrasensitive method to quantitate total PSA in serum (1998) (13)
- Sulfur amino acid metabolism in hepatobiliary disorders. (1992) (13)
- Comparison of activities of isocitric dehydrogenase and glutamic-oxalacetic transaminase in serum infectious hepatitis. (1960) (13)
- Problems in the interpretation of serum cholesterol values. (1972) (13)
- Comparison of Roche RIA, Roche EIA, Hybritech EIA, and Abbott EIA methods for measuring carcinoembryonic antigen. (1988) (12)
- Chemical and clinical evaluation of the random access analyzer "RA-1000". (1984) (12)
- Automated flame photometry of serum sodium and potassium. (1971) (12)
- AUTOMATION OF ENZYME DETERMINATIONS: PHOSPHOHEXOSE ISOMERASE * (1960) (11)
- Carcinoembryonic antigen in children with neuroblastoma. (1976) (11)
- Automated method for determination of serum 5'-nucleotidase activity. (1972) (11)
- An automated, fluorometric procedure for determining serum lipase. (1971) (11)
- Alkaline and acid phosphatases. (1961) (11)
- Metabolism in surgical patients. III. Effect of drugs and dietary procedures on fat and nitrogen metabolism in totally gastrectomized patients. (1956) (10)
- Evaluation of HPLC column performance for clinical studies. (1985) (10)
- The action of acid phosphatase from cancerous and noncancerous human prostate on various substrates (1953) (10)
- Glycolytic and related enzymes. (1961) (10)
- Cerebrospinal fluid biochemical markers of central nervous system metastasis. (1978) (9)
- Breast cancer marker Ca549. A multicenter study. (1994) (9)
- CEA in colonic lavage of individuals at high risk for large bowel cancer (1978) (9)
- Biochemistry of malignant melanoma. (1976) (9)
- pH as a marker of breast cyst fluid biochemical type. (1987) (9)
- [99] Phosphohexose isomerase: Clinical aspects (1966) (9)
- Comparison of carcinoembryonic antigen (CEA) methodologies. (1974) (8)
- Neuron-specific enolase and retinoblastoma. Clinicopathologic correlations. (1989) (8)
- International Federation of Clinical Chemistry (IFCC), Education Committee and International Union of Pure and Applied Chemistry. Guidelines (1985) for teaching of clinical chemistry to medical students. (1985) (8)
- Enzyme patterns in cancer. (1977) (8)
- Estrogen and progesterone receptor proteins in patients with breast cancer. (1993) (8)
- Enzyme tests in cancer. (1982) (7)
- Urinary lactic dehydrogenase in genitourinary tract diseases. (1969) (7)
- Use of evacuated collection tubes for routine determination of arterial blood gases and pH. (1971) (7)
- A basic education and training framework for medical laboratory technicians in clinical chemistry (1984) (7)
- Plasma Proteins in Health and Disease (1963) (7)
- Argument in favor of using mass units to calibrate and report concentrations of human choriogonadotropin. (1986) (6)
- Screening for cancer: is it cost effective? (1993) (5)
- USE OF COMMERCIALLY AVAILABLE PREPARATIONS OF FRUCTOSE 6-PHOSPHATE IN THE DETERMINATION OF PHOSPHOHEXOSE ISOMERASE ACTIVITY. (1965) (5)
- SERUM BILE ACIDS IN PATIENTS WITH LIVER DISEASE. (1965) (5)
- Biochemical procedures as aids in diagnosis of different forms of cancer. (1974) (5)
- Changes in serum alpha-fetoprotein and chorionic gonadotropin in response to cancer therapy. (1984) (5)
- Multicenter evaluation of the Bayer Immuno I CA 15-3 assay. (1998) (5)
- Cystathionine excess in children with hepatic cancer. (1973) (5)
- [2] Automated enzyme analysis-general (1971) (4)
- Measurement of anti-folate analogs. (1992) (4)
- Effect of 5-dydroxyindolylacetic acid in the colorimetric determination of urinary vanilmandelic acid. (1969) (4)
- Solid-phase enzyme immunoassay of terminal deoxynucleotidyl transferase evaluated. (1987) (4)
- The distribution and clearance of L-asparaginase. (1970) (4)
- Effects and concentrations of L-asparagin-ase in intracerebrally inoculated leukemia. (1968) (4)
- The role of the laboratory in the prevention and detection of chronic disease. (1992) (4)
- TUMOR MARKERS IN THE PATIENT WITH LUNG CANCER (1987) (4)
- Tumor markers: what is their role? (1990) (4)
- Circulating and tissue markers in the longitudinal management of breast cancer patients. (1994) (4)
- Clinical chemistry : trace metals (1991) (3)
- Clinical evaluation of the VMA test strip. (1973) (3)
- Laboratory diagnosis for cancer: a look at the future. (1978) (3)
- Effect of storage in deep freeze upon activity of urinary acid phosphatase. (1956) (3)
- Estrogen receptor protein in visceral metastases from breast carcinoma. (1981) (3)
- Recent advances in calcium and phosphorus metabolism. (1975) (3)
- Guidelines (1985) for clinical chemists for effective communication of clinical chemistry laboratory data. IFCC Document Stage 2, Draft 3. (1986) (3)
- Preclinical determination of AIDS disease by a series of tests. (1986) (3)
- Measurement of 5′-Nucleotidase Activity in Serum (1972) (3)
- Cerebrospinal fluid markers in central nervous system metastases from testicular carcinoma. (1979) (3)
- International Federation of Clinical Chemistry, Education Committee: and International Union of Pure and Applied Chemistry, Division of Clinical Chemistry: guidelines (1985) for clinical chemists for effective communication of clinical chemistry laboratory data. (1985) (2)
- Biochemical procedures in different forms of cancer. (1971) (2)
- Blood groups and response to therapy for mammary cancer. (1977) (2)
- Prostatic Specific Antigen, Prostatic Acid Phosphatase and Acid Phosphatase in Patients with Prostate Cancer and Benign Prostatic Hyperplasia (1987) (2)
- Placental alterations in toxemia of pregnancy in the guinea pig. (1958) (2)
- Advances in the use of tumor markers. (1990) (2)
- Comparison of assays for prostatic and total acid phosphatase. (1990) (2)
- Performance evaluation of a blood gas system in a central and satellite laboratory. (1979) (2)
- Immunoassay of enzymes--an overview. (1983) (2)
- Biochemical Markers in Cancer (1981) (2)
- 14. Lung Cancer (1987) (2)
- [261a] Clinical aspects of arginase☆☆☆ (1971) (2)
- Stac sequential test analyzer with computer an initial evaluation (1978) (1)
- Post-doctoral training of the non-physician doctoral scientist. (1994) (1)
- Biochemical and immunologic diagnosis of cancer. Germ cell tumors. (1987) (1)
- 66 Aminoglutethimide as late treatment of metastatic breast cancer (1983) (1)
- Estrogen binding and estrogen receptor activity in the human prostate: a preliminary report. (1981) (1)
- GOT and GPT, Assay with Automatic Analysers* (1974) (1)
- Relevance of steroid receptor measurements in the diagnosis and therapeutic management of cancer patients. (1979) (1)
- Hormone analysis: bioassay and immunochemical methodology. (1975) (1)
- Book ReviewGradwohl's Clinical Laboratory Methods and Diagnosis. Vols. 1 and 2. (1981) (1)
- Biochemical and immunologic diagnosis of cancer. Lung cancer. (1987) (1)
- Introduction to Technology Section (1983) (1)
- The two stage provocative test for pancreatic disease by serum enzyme measurements. (1980) (1)
- Consensus Report, 1987 (1987) (1)
- Observations on serum enzyme alterations in experimental renal ischemia. (1973) (1)
- Fecal Occult Blood Screening Tests (1986) (1)
- Detection of Tumor-Associated Antigens in Plasma or Serum (1976) (1)
- Vegetable peroxidase inhibitor--an improvement in the guaiac fecal occult blood test. (1985) (1)
- Monographs on Endocrinology 7: Prostaglandins. E. W. Horton. Springer-Verlag, New York, Inc., 175 Fifth Avenue, New York, N. Y. 10010, 1972, xi + 197 pp. $18.20 (1972) (1)
- Tumour markers, enzymes and hormonal markers. (1976) (0)
- State of the art in automated analysis. (1974) (0)
- The Increase of Thyroid Abnormalities, Elevated Serum Beta Globulins and Type A Blood Group in Paget's Disease. (1966) (0)
- UrinaryCystathionine, Catecholamine, and Metabolites in Patients withNeuroblastoma (1972) (0)
- An evaluation of a non-isotopic homogeneous enzyme immunoassay (CEDIA assay) for cortisol and its clinical utility. (1992) (0)
- Estrogen receptors and tumor associated antigens in breast cancer. (1979) (0)
- Definition of the terms certification, licensure and accreditation in clinical chemistry. IFCC Document Stage 2, Draft 3. (1986) (0)
- [261b] Clinical aspects of l-asparaginase☆☆☆ (1971) (0)
- Bone tumors. (1990) (0)
- Acute-phase reactants as tumor markers. (1995) (0)
- Solid-Phase EnzymeImmunoassay ofTerminalDeoxynucleotidyl Transferase Evaluated (1987) (0)
- Biochemistry of Human Cancer. O. Bodansky. Academic Press, New York, N. Y. 10003, 1975, xiv + 657 pp. $39.50 (1975) (0)
- Cancer Markers: Diagnostic and Developmental Significance. S. Sell, Ed. The Humana Press, Inc., Clifton, NJ 07015. xxvii + 541 pp. Pub. Jan. 1980. $49.50 (1980) (0)
- A review of methodology for estrogen and progesterone receptor protein analysis. (1992) (0)
- Solvingthe Problemof AntibodyInterferencein Commercial “ Sandwich ”-TypeImmunoassays of CarcinoembryonicAntigen (2004) (0)
- Substate specificity of phosphatase (1952) (0)
- DeterminingSerum Lipase (2004) (0)
- Automation and Data Processing in the Clinical Laboratory. G. M. Brittin and M. Werner, Eds. Charles C Thomas, Springfield, Ill. 1970, x + 174 pp. $13.50 (1970) (0)
- Sex Hormones in Patients with Benign Prostatic Hyperplasia: A Comparison of Prostate Volume with Steroid Hormone Levels (1987) (0)
- Timor Antigens and Other Tumor Markers: Their Effectiveness in Cancer Diagnosis (1982) (0)
- Biochemical and immunochemical markers associated with cancer. (1976) (0)
- Procedure for examination of brystcystevaeske the risk of cancer (1985) (0)
- The real world--regulations and ethics. (1992) (0)
- Metastatic AdrenalCorticalCarci noma:Biochemical Changes Accompanying ClinicalRegression DuringTherapy with01p'-DDD' (1971) (0)
- Observations on serum enzyme alterations in experimental renal ischemia. (1973) (0)
- Breast cancer: alternative therapy. Hormone receptor assay. (1977) (0)
- Oxaloacetic Transaminase in Human Tissues to the Patterns in Serum of Patients with Neoplastic Disease (1966) (0)
- Advances in Enzymology, 39. A. Meister, Ed., John Wiley & Sons, New York, N. Y. 10016, 1973, v + 487 pp. $22.50 (1974) (0)
- The determination of quinidine in blood (1949) (0)
- Trlclonai Gammopathy In a Patient (2000) (0)
- Routine use of beta 2-microglobulin assays. (1987) (0)
- Biochemical Characteristics of 5′-Nucleotidase and Diagnostic Utilization of Its Activity in Human Serum. (1967) (0)
- The effect of a gluten-free diet on fat, nitrogen, and mineral metabolism in patients with sprue. (1968) (0)
- Vitamins and Coenzymes. Vol. XVIII. Part A. Methods in Enzymology. D.B. McCormick and L.D. Wright, Eds., Academic Press, Inc., 111 Fifth Ave., New York, N. Y. 10003. 1970, xxi + 688 pp. $29.50 (1971) (0)
- How do we detect hereditary large bowel cancer? Biochemical diagnosis. (1983) (0)
- Human tumor markers : proceedings of the International Symposium on Human Tumor Markers held in Taipei, Taiwan, R.O.C., 3-5 September 1988 (1989) (0)
- Direct RadloImmunoassay of MelatonlnIn Saliva (2004) (0)
- Section Meeting on Early Diagnosis, Prevention, and Human Genetics (1974) (0)
- In Reply: Phosphohexose Isomerase In Lung Cancer (1988) (0)
- Comparisonof Roche RIA , Roche EIA , HybritechEIA , and Abbott EIA Methodsfor Measunng CarcinoembryonicAntigen (2004) (0)
- Vitamins and Coenzymes, XVIII, Part C, Methods in Enzymology. D. B. McCormick and L. D. Wright, Eds. Academic Press, Inc., New York, N. Y. 10003, 1971, xviii + 786 pp. $32.00 (1972) (0)
- Book Review Interpretation of Protein and Isoenzyme Patterns in Body Fluids By Tsieh Sun. 255 pp., illustrated. New York, Igaku—Shoin, 1991. $69.50. (1992) (0)
- Hormone Receptor Assay (1977) (0)
- Reply of the authors: Hemoccult Testing (1977) (0)
- Book Review:Alpha-Fetoprotein and Hepatoma. Hidematsu Hirai, Toru Miyaji (1974) (0)
- Variation in the Quantitation of Prostate-specific Anti- gen in Reference Material: Differences in Commercial (1998) (0)
- Measurementof Total Alkaline PhosphataseActivityin HumanSerum (1988) (0)
- Biochemistry: Practical Clinical Enzymology . By J. King. Van Nostrand, Princeton, N.J., 1965. 363 pp., $12.50. (1966) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Morton Kanter Schwartz?
Morton Kanter Schwartz is affiliated with the following schools: